Influence of Epithelial-Mesenchymal Transition on Risk of Relapse and Outcome to Eribulin or Cyclin-Dependent Kinase Inhibitors in Metastatic Breast Cancer Patients with NSCLC who had CSF collection ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback